Related references
Note: Only part of the references are listed.Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Use of microfluidics to assess the platelet-based control of coagulation
Magdolna Nagy et al.
PLATELETS (2017)
Factor Villa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens
Takehisa Kitazawa et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?
Peter J. Lenting et al.
BLOOD (2017)
Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease
V. Daidone et al.
HAEMOPHILIA (2016)
Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA® in prophylactic therapy
K. Varadi et al.
HAEMOPHILIA (2016)
The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline
L. M. Aledort
HAEMOPHILIA (2016)
Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system
K. Nogami et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy
Y. Arima et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Advances in the treatment of bleeding disorders
F. Peyvandi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A
Midori Shima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors
Elena Santagostino et al.
BLOOD REVIEWS (2015)
Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors
N. Ewing et al.
HAEMOPHILIA (2015)
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
Elena N. Lipets et al.
THROMBOSIS JOURNAL (2015)
The impact of blood shear rate on arterial thrombus formation
Kjell S. Sakariassen et al.
FUTURE SCIENCE OA (2015)
The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors
Hee Young Ju et al.
BLOOD RESEARCH (2015)
Factor VIII therapy for hemophilia A: current and future issues
Louis Aledort et al.
EXPERT REVIEW OF HEMATOLOGY (2014)
Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery
Alexander Hincker et al.
CRITICAL CARE (2014)
Global coagulation in myeloproliferative neoplasms
Armando Tripodi et al.
ANNALS OF HEMATOLOGY (2013)
Bringing flow into haemostasis diagnostics
U. Schott et al.
BRITISH JOURNAL OF ANAESTHESIA (2013)
Persistence of Hypercoagulable State after Resection of Intra-Abdominal Malignancies
Chad M. Thorson et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2013)
Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
Zenjiro Sampei et al.
PLOS ONE (2013)
Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood
Sabine Knappe et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals
Yusuke Yamaguchi et al.
THROMBOSIS RESEARCH (2013)
Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood
S. Ogawa et al.
HAEMOPHILIA (2012)
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa et al.
NATURE MEDICINE (2012)
Predictability of serious adverse reaction alerts for monoclonal antibodies
V. Stanulovic et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry
R Parameswaran et al.
HAEMOPHILIA (2005)
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation
B Sorensen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Share Paper
